SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-123925
Filing Date
2020-11-12
Accepted
2020-11-12 07:01:36
Documents
16
Period of Report
2020-11-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035777d1_8k.htm   iXBRL 8-K 25520
2 EXHIBIT 99.1 tm2035777d1_ex99-1.htm EX-99.1 15187
3 EXHIBIT 99.2 tm2035777d1_ex99-2.htm EX-99.2 18859
7 GRAPHIC tm2035777d1_ex99-1img01.jpg GRAPHIC 8680
8 GRAPHIC tm2035777d1_ex99-2img01.jpg GRAPHIC 8680
  Complete submission text file 0001104659-20-123925.txt   269002

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA espr-20201110.xsd EX-101.SCH 3186
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20201110_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20201110_pre.xml EX-101.PRE 22710
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2035777d1_8k_htm.xml XML 3625
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 201303279
SIC: 2834 Pharmaceutical Preparations